ZBH רווח נקי למניה (EPS TTM) zimmerbiomet.com

Rising demand driven by an aging population provides Zimmer Biomet Holdings (ZBH) with a steady stream of revenue. Current trailing twelve-month earnings per share on GURU.Markets reflects this trend, where 3.94 determines the latest valuation metric. High liquidity and the ability to cover capex with cash confirm the company's financial health, while its global brand authority in orthopedics ensures the trust of leading surgeons.
פילוחים אנליטיים ודוחות נתונים של חברת Zimmer (ZBH)

This indicator reflects the net income distributed per common share over the last 12 months, allowing for an assessment of real capital generation efficiency without accounting for shareholder dilution. Analyzing the TTM earnings per share is critical for identifying margin compression risks during debt refinancing, especially given the high cost of borrowing. Steady growth in this metric confirms the resilience of the Zimmer Biomet Holdings (ZBH) business model, which relies on patent protection and surgeon loyalty.